Low-Load BFR vs. High-Load Training on Biceps Hypertrophy

May 2, 2026 updated by: Huseyin Sahin UYSAL, Mehmet Akif Ersoy University

Bayesian Comparison of Low-Load Blood Flow Restriction and High-Load Resistance Exercise on Biceps Brachii Muscle Hypertrophy in Untrained Men

This study aimed to compare the effects of low-load blood flow restriction resistance exercise (BFR-RE) performed to voluntary failure with traditional high-load resistance exercise (HL-RE) and a control condition on biceps brachii muscle hypertrophy, muscle stiffness, and maximal strength in untrained young men.

Participants completed an 8-week training program, with exercise performed three times per week. Outcomes were assessed using ultrasound imaging, elastography, and one-repetition maximum (1RM) testing. The study evaluates whether low-load BFR training can produce adaptations comparable to high-load resistance training.

Study Overview

Detailed Description

This study was designed to examine the efficacy of low-load blood flow restriction resistance exercise (BFR-RE) performed to voluntary failure compared with traditional high-load resistance exercise (HL-RE) in inducing muscular adaptations in untrained individuals. The experimental framework was structured to isolate the effects of mechanical load and metabolic stress by standardizing the selection of exercises and the training frequency across groups.

A controlled, single-blind, repeated-measures design was used, with participants allocated to BFR-RE, HL-RE, or a non-exercising control condition. The intervention period was set at 8 weeks to ensure sufficient exposure for hypertrophic and neuromuscular adaptations, while minimizing potential confounding effects of long-term training variability.

The BFR-RE protocol was developed to emphasize metabolic stress through low external loading (30% 1RM), partial vascular occlusion (60% limb occlusion pressure), and sets performed to volitional failure. In contrast, the HL-RE condition was structured to prioritize mechanical tension using moderate-to-high loading (70% 1RM) without vascular restriction. This contrast enables a mechanistic comparison of two distinct hypertrophic stimuli.

To reduce acute exercise-induced confounding factors, particularly transient muscle swelling, post-intervention assessments were complemented with a delayed follow-up measurement. This approach was incorporated better to reflect true morphological adaptations rather than short-term physiological responses.

The methodological approach integrates imaging-based and performance-based assessments to capture both structural and functional adaptations. The overall design enables evaluation of whether BFR-RE can provide a time-efficient and lower-load alternative to traditional resistance training while maintaining comparable adaptive outcomes.

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Karabük Province
      • Karabük, Karabük Province, Turkey (Türkiye), 78050
        • Karabük University Hasan Dogan Faculty of Sport Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Healthy male participants aged 18-30 years No prior history of structured or specialized resistance training targeting the biceps brachii muscle Normotensive (blood pressure <140/90 mmHg) Right-handed (to reduce variability related to limb dominance) Willing to provide written informed consent and comply with the study protocol

Exclusion Criteria:

History of orthopedic injury or musculoskeletal disorder affecting the upper extremities Diagnosis of hypertension (≥140/90 mmHg) or cardiovascular disease Any neurological condition affecting motor performance Current participation in any structured resistance training program Use of medications or supplements known to influence muscle metabolism or performance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BFR-RE
Participants performed low-load resistance exercise with blood flow restriction using 30% of one-repetition maximum (1RM) and 60% limb occlusion pressure. Exercises were performed to voluntary failure, three times per week for 8 weeks.
Resistance exercise was performed under partial vascular occlusion using a pneumatic cuff applied to the upper arm. Limb occlusion pressure was individually determined, and exercise was conducted at a relative intensity corresponding to a percentage of one-repetition maximum. Occlusion pressure was maintained during sets and released between exercises. Training load and repetition tempo were standardized and progressively adjusted throughout the intervention period.
Other Names:
  • BFR Training
Active Comparator: HL-RE
Participants performed traditional high-load resistance exercise at 70% of one-repetition maximum (1RM) without blood flow restriction, three times per week for 8 weeks.
Participants performed resistance exercise using conventional loading strategies based on a percentage of one-repetition maximum. Training intensity, volume, and progression were standardized across sessions, with loads adjusted periodically according to performance assessments.
Other Names:
  • Traditional Resistance Training
No Intervention: Control
Participants did not engage in any structured resistance training program and continued their normal daily activities throughout the 8-week study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biceps Brachii Muscle Thickness
Time Frame: Baseline and 8 weeks (post-intervention), with an additional follow-up measurement at 1 week after the intervention
Muscle thickness of the biceps brachii was assessed using ultrasound imaging to evaluate hypertrophic adaptations following the intervention.
Baseline and 8 weeks (post-intervention), with an additional follow-up measurement at 1 week after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Actual)

August 3, 2025

Study Completion (Actual)

August 3, 2025

Study Registration Dates

First Submitted

April 24, 2026

First Submitted That Met QC Criteria

April 24, 2026

First Posted (Actual)

May 1, 2026

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 2, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Mehmet Akif Ersoy Universitesi
  • BFR_HLRE_UntrainedMen (Registry Identifier: Bayesian Comparison of Low-Load Blood Flow Restriction and High-Load Resistance Exercise on Biceps Brachii Muscle Hyper)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe